[Possibilities for the evaluation of receptor sites in benign prostatic hyperplasia and carcinoma of the prostate (author's transl)]. 1980

D Fischer, and W Gevers, and M Bressel

Cytoplasmic and nuclear receptor sites of the prostate will be determined for a qualitative information about the pattern of specific bindings. Their qualitative evaluation and their selective suppression will give an idea about the hormonal influence and regulation in prostatic tissue. These investigations are performed in some cases of prostatic cancer. The difficulty of tissue preparation is caused by the individual distribution of collagen tissue in prostatic cancer which will decide the yield of purified receptor sites. Besides the elemination of unspecific binding sites like SHBG and albumin is an evidence for the value of a method. According to high amount of binding sites the most effective preparation of patients before a tissue biopsy is discussed. For the clinical application the DCC test in case of cytoplasmic sites and the exchange test for nuclear sites seem to provide a suitable method. Performing gelfiltration and additional test with denatured material is necessary because of the similar size of SHBG and receptor complexes interfering the results.

UI MeSH Term Description Entries
D008297 Male Males
D011470 Prostatic Hyperplasia Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both. Adenoma, Prostatic,Benign Prostatic Hyperplasia,Prostatic Adenoma,Prostatic Hyperplasia, Benign,Prostatic Hypertrophy,Prostatic Hypertrophy, Benign,Adenomas, Prostatic,Benign Prostatic Hyperplasias,Benign Prostatic Hypertrophy,Hyperplasia, Benign Prostatic,Hyperplasia, Prostatic,Hyperplasias, Benign Prostatic,Hypertrophies, Prostatic,Hypertrophy, Benign Prostatic,Hypertrophy, Prostatic,Prostatic Adenomas,Prostatic Hyperplasias, Benign,Prostatic Hypertrophies
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

D Fischer, and W Gevers, and M Bressel
April 1980, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
D Fischer, and W Gevers, and M Bressel
April 1982, Therapeutische Umschau. Revue therapeutique,
D Fischer, and W Gevers, and M Bressel
April 1982, Therapeutische Umschau. Revue therapeutique,
D Fischer, and W Gevers, and M Bressel
August 1994, Medizinische Monatsschrift fur Pharmazeuten,
D Fischer, and W Gevers, and M Bressel
October 1986, Nihon Ika Daigaku zasshi,
D Fischer, and W Gevers, and M Bressel
January 1991, Scandinavian journal of urology and nephrology. Supplementum,
D Fischer, and W Gevers, and M Bressel
January 2012, Indian journal of urology : IJU : journal of the Urological Society of India,
D Fischer, and W Gevers, and M Bressel
June 2000, BJU international,
D Fischer, and W Gevers, and M Bressel
November 1977, The Journal of clinical endocrinology and metabolism,
D Fischer, and W Gevers, and M Bressel
May 2001, The Prostate,
Copied contents to your clipboard!